Jenani, Fhaira B.
HRN: 22-19-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/17/2022
11/23/2022
IVT
150mg
OD
URTI
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes